Article Details

The Goldman Sachs Group Trims Karuna Therapeutics (NASDAQ:KRTX) Target Price to $171.00

Retrieved on: 2021-05-13 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

The Goldman Sachs Group Trims Karuna Therapeutics (NASDAQ:KRTX) Target Price to $171.00. View article details on hiswai:

Excerpt

The firm presently has a "buy" rating on the stock. The Goldman Sachs Group's price target would suggest a potential upside of 47.82% from the stock's ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up